Skip to main content
Top
Published in: BMC Public Health 1/2010

Open Access 01-12-2010 | Research article

Referrals for positive tuberculin tests in new health care workers and students: a retrospective cohort study

Authors: Yining Xu, Kevin Schwartzman

Published in: BMC Public Health | Issue 1/2010

Login to get access

Abstract

Background

Documentation of test results for latent tuberculosis (TB) infection is important for health care workers and students before they begin work. A negative result provides a baseline for comparison with future tests. A positive result affords a potential opportunity for treatment of latent infection when appropriate. We sought to evaluate the yield of the referral process for positive baseline tuberculin tests, among persons beginning health care work or studies.

Methods

Retrospective cohort study. We reviewed the charts of all new health care students and workers referred to the Montreal Chest Institute in 2006 for positive baseline tuberculin skin tests (≥10 mm). Health care workers and students evaluated for reasons other than positive baseline test results were excluded.

Results

630 health care students and workers were evaluated. 546 (87%) were foreign-born, and 443 (70%) reported previous Bacille Calmette-Guérin (BCG) vaccination. 420 (67%) were discharged after their first evaluation without further treatment. 210 (33%) were recommended treatment for latent TB infection, of whom 165 (79%) began it; of these, 115 (70%) completed adequate treatment with isoniazid or rifampin. Treatment discontinuation or interruption occurred in a third of treated subjects, and most often reflected loss to follow-up, or abdominal discomfort. No worker or student had active TB.

Conclusions

Only a small proportion of health care workers and students with positive baseline tuberculin tests were eligible for, and completed treatment for latent TB infection. We discuss recommendations for improving the referral process, so as to better target workers and students who require specialist evaluation and treatment for latent TB infection. Treatment adherence also needs improvement.
Appendix
Available only for authorised users
Literature
2.
go back to reference Dye C: Global epidemiology of tuberculosis. Lancet. 2006, 367: 938-940. 10.1016/S0140-6736(06)68384-0.CrossRefPubMed Dye C: Global epidemiology of tuberculosis. Lancet. 2006, 367: 938-940. 10.1016/S0140-6736(06)68384-0.CrossRefPubMed
3.
go back to reference Joshi R, Reingold AL, Menzies D, Pai M: Tuberculosis among health-care workers in low- and middle-income countries: a systematic review. PLoS Medicine. 2006, 3: e494-10.1371/journal.pmed.0030494.CrossRefPubMedPubMedCentral Joshi R, Reingold AL, Menzies D, Pai M: Tuberculosis among health-care workers in low- and middle-income countries: a systematic review. PLoS Medicine. 2006, 3: e494-10.1371/journal.pmed.0030494.CrossRefPubMedPubMedCentral
4.
go back to reference Menzies D, Fanning A, Yuan L, Fitzgerald M: Tuberculosis among health care workers. N Engl J Med. 1995, 332: 92-98. 10.1056/NEJM199501123320206.CrossRefPubMed Menzies D, Fanning A, Yuan L, Fitzgerald M: Tuberculosis among health care workers. N Engl J Med. 1995, 332: 92-98. 10.1056/NEJM199501123320206.CrossRefPubMed
6.
go back to reference Schwartzman K, Loo V, Pasztor J, Menzies D: Tuberculosis infection among health care workers in Montreal. Am J Respir Crit Care Med. 1996, 154: 1006-1012.CrossRefPubMed Schwartzman K, Loo V, Pasztor J, Menzies D: Tuberculosis infection among health care workers in Montreal. Am J Respir Crit Care Med. 1996, 154: 1006-1012.CrossRefPubMed
7.
go back to reference Menzies D, Fanning A, Yuan L, FitzGerald JM: Hospital ventilation and risk for tuberculous infection in Canadian health care workers. Ann Intern Med. 2000, 133: 779-789.CrossRefPubMed Menzies D, Fanning A, Yuan L, FitzGerald JM: Hospital ventilation and risk for tuberculous infection in Canadian health care workers. Ann Intern Med. 2000, 133: 779-789.CrossRefPubMed
8.
go back to reference Griffith DE, Hardman JL, Zhang Y, Wallace RJ, Mazurek GH: Tuberculosis outbreak among health care workers in a community hospital. Am J Respir Crit Care Med. 1995, 152: 808-811.CrossRefPubMed Griffith DE, Hardman JL, Zhang Y, Wallace RJ, Mazurek GH: Tuberculosis outbreak among health care workers in a community hospital. Am J Respir Crit Care Med. 1995, 152: 808-811.CrossRefPubMed
9.
go back to reference Sterling TR, Haas DW: Transmission of Mycobacterium tuberculosis from health care workers. N Engl J Med. 2006, 355: 118-121. 10.1056/NEJMp068015.CrossRefPubMed Sterling TR, Haas DW: Transmission of Mycobacterium tuberculosis from health care workers. N Engl J Med. 2006, 355: 118-121. 10.1056/NEJMp068015.CrossRefPubMed
10.
go back to reference Centers for Disease Control and Prevention: Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. 2005, CDC MMWR, 54 (No. RR-17): 1-140. Centers for Disease Control and Prevention: Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. 2005, CDC MMWR, 54 (No. RR-17): 1-140.
12.
go back to reference American Thoracic Society/Centers for Disease Control and Prevention: Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000, 161: 5221-5247. American Thoracic Society/Centers for Disease Control and Prevention: Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000, 161: 5221-5247.
13.
go back to reference American Thoracic Society/Centers for Disease Control and Prevention: Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and Revisions in American Thoracic Society/CDC Recommendations--United States, 2001. 2001, CDC MMWR, 50 (34): 733-735. American Thoracic Society/Centers for Disease Control and Prevention: Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and Revisions in American Thoracic Society/CDC Recommendations--United States, 2001. 2001, CDC MMWR, 50 (34): 733-735.
14.
go back to reference Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, Memish Z, Khan K, Gardam M, Hoeppner V, Benedetti A, Schwartzman K: Adverse events with 4 months rifampin or 9 months isoniazid as therapy for latent TB infection: results of a randomized trial. Ann Intern Med. 2008, 149: 689-697.CrossRefPubMed Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, Memish Z, Khan K, Gardam M, Hoeppner V, Benedetti A, Schwartzman K: Adverse events with 4 months rifampin or 9 months isoniazid as therapy for latent TB infection: results of a randomized trial. Ann Intern Med. 2008, 149: 689-697.CrossRefPubMed
15.
go back to reference Menzies D, Fanning A, Yuan L, Mark FitzGerald J, Canadian Collaborative Group in Nosocomial Transmission of Tuberculosis: Tuberculosis in health care workers: a multicentre Canadian prevalence survey: preliminary results. Int J Tuberc Lung Dis. 1998, 2: S98-S102.PubMed Menzies D, Fanning A, Yuan L, Mark FitzGerald J, Canadian Collaborative Group in Nosocomial Transmission of Tuberculosis: Tuberculosis in health care workers: a multicentre Canadian prevalence survey: preliminary results. Int J Tuberc Lung Dis. 1998, 2: S98-S102.PubMed
16.
go back to reference Menzies R, Vissandjee B: Effect of Bacille Calmette-Guerin vaccination on tuberculin reactivity. Am Rev Respir Dis. 1992, 145: 621-645.CrossRefPubMed Menzies R, Vissandjee B: Effect of Bacille Calmette-Guerin vaccination on tuberculin reactivity. Am Rev Respir Dis. 1992, 145: 621-645.CrossRefPubMed
17.
go back to reference Menzies D: Interpretation of repeated tuberculin tests: Boosting, conversion and reversion. Am J Respir Crit Care Med. 1999, 159: 15-21.CrossRefPubMed Menzies D: Interpretation of repeated tuberculin tests: Boosting, conversion and reversion. Am J Respir Crit Care Med. 1999, 159: 15-21.CrossRefPubMed
18.
go back to reference Shukla SJ, Warren DK, Woeltje KF, Gruber CA, Fraser VJ: Factors associated with the treatment of latent tuberculosis infection among health-care workers at a Midwestern teaching hospital. Chest. 2002, 122: 1609-1614. 10.1378/chest.122.5.1609.CrossRefPubMed Shukla SJ, Warren DK, Woeltje KF, Gruber CA, Fraser VJ: Factors associated with the treatment of latent tuberculosis infection among health-care workers at a Midwestern teaching hospital. Chest. 2002, 122: 1609-1614. 10.1378/chest.122.5.1609.CrossRefPubMed
19.
go back to reference Salpeter SR, Salpeter EE: Screening and treatment of latent tuberculosis among healthcare workers at low, moderate, and high risk for tuberculosis exposure: a cost-effectiveness analysis. Infect Control Hosp Epidemiol. 2004, 25: 1056-1061. 10.1086/502343.CrossRefPubMed Salpeter SR, Salpeter EE: Screening and treatment of latent tuberculosis among healthcare workers at low, moderate, and high risk for tuberculosis exposure: a cost-effectiveness analysis. Infect Control Hosp Epidemiol. 2004, 25: 1056-1061. 10.1086/502343.CrossRefPubMed
20.
go back to reference Gershon AS, McGeer A, Bayoumi AM, Raboud J, Yang J: Health care workers and the initiation of treatment for latent tuberculosis infection. Clin Infect Dis. 2004, 39: 667-672. 10.1086/422995.CrossRefPubMed Gershon AS, McGeer A, Bayoumi AM, Raboud J, Yang J: Health care workers and the initiation of treatment for latent tuberculosis infection. Clin Infect Dis. 2004, 39: 667-672. 10.1086/422995.CrossRefPubMed
21.
go back to reference Lambert L, Rajbhandary S, Quails N, Budnick L, Catanzaro A, Cook S, Daniels-Cuevas L, Garber E, Reves R: Costs of implementing and maintaining a tuberculin skin test program in hospitals and health departments. Infect Control Hosp Epidemiol. 2003, 24: 814-820. 10.1086/502142.CrossRefPubMed Lambert L, Rajbhandary S, Quails N, Budnick L, Catanzaro A, Cook S, Daniels-Cuevas L, Garber E, Reves R: Costs of implementing and maintaining a tuberculin skin test program in hospitals and health departments. Infect Control Hosp Epidemiol. 2003, 24: 814-820. 10.1086/502142.CrossRefPubMed
22.
go back to reference Camins BC, Bock N, Watkins DL, Blumberg HM: Acceptance of isoniazid preventive therapy by health care workers after tuberculin skin test conversion. JAMA. 1996, 275: 1013-1015. 10.1001/jama.275.13.1013.CrossRefPubMed Camins BC, Bock N, Watkins DL, Blumberg HM: Acceptance of isoniazid preventive therapy by health care workers after tuberculin skin test conversion. JAMA. 1996, 275: 1013-1015. 10.1001/jama.275.13.1013.CrossRefPubMed
23.
go back to reference LoBue PA, Catanzaro A: Effectiveness of a nosocomial tuberculosis control program at an urban teaching hospital. Chest. 1998, 113: 1184-1189. 10.1378/chest.113.5.1184.CrossRefPubMed LoBue PA, Catanzaro A: Effectiveness of a nosocomial tuberculosis control program at an urban teaching hospital. Chest. 1998, 113: 1184-1189. 10.1378/chest.113.5.1184.CrossRefPubMed
24.
go back to reference Fraser VJ, Kilo CM, Bailey TC, Medoff G, Dunagan WC: Screening of physicians for tuberculosis. Infect Control Hosp Epidemiol. 1994, 15: 95-100. 10.1086/646868.CrossRefPubMed Fraser VJ, Kilo CM, Bailey TC, Medoff G, Dunagan WC: Screening of physicians for tuberculosis. Infect Control Hosp Epidemiol. 1994, 15: 95-100. 10.1086/646868.CrossRefPubMed
25.
go back to reference Committee on the elimination of tuberculosis in the United States, Division of health promotion and disease prevention, Institute of Medicine: Ending neglect: the elimination of tuberculosis in the United States. 2000, Washington: National Academy Press Committee on the elimination of tuberculosis in the United States, Division of health promotion and disease prevention, Institute of Medicine: Ending neglect: the elimination of tuberculosis in the United States. 2000, Washington: National Academy Press
26.
go back to reference Dasgupta K, Schwartzman K, Marchand R, Tannenbaum TN, Brassard P, Menzies D: Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations. Am J Respir Crit Care Med. 2001, 162: 2079-2086.CrossRef Dasgupta K, Schwartzman K, Marchand R, Tannenbaum TN, Brassard P, Menzies D: Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations. Am J Respir Crit Care Med. 2001, 162: 2079-2086.CrossRef
27.
go back to reference Oxlade O, Schwartzman K, Menzies D: Interferon-gamma release assays and TB screening in high-income countries: A cost-effectiveness analysis. Int J Tuberc Lung Dis. 2007, 11: 16-26.PubMed Oxlade O, Schwartzman K, Menzies D: Interferon-gamma release assays and TB screening in high-income countries: A cost-effectiveness analysis. Int J Tuberc Lung Dis. 2007, 11: 16-26.PubMed
28.
go back to reference Schwartzman K, Menzies D: Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis. Am J Respir Crit Care Med. 2000, 161: 780-789.CrossRefPubMed Schwartzman K, Menzies D: Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis. Am J Respir Crit Care Med. 2000, 161: 780-789.CrossRefPubMed
29.
go back to reference Sahni R, Miranda C, Yen-Lieberman B, Tomford JW, Terpeluk P, Quartey P, Johnson LT, Gordon SM: Does the implementation of an Interferon-γ release assay in lieu of a tuberculin skin test increase acceptance of preventive therapy for latent tuberculosis among healthcare workers?. Infect Control Hosp Epidemiol. 2009, 30: 197-199. 10.1086/593965.CrossRefPubMed Sahni R, Miranda C, Yen-Lieberman B, Tomford JW, Terpeluk P, Quartey P, Johnson LT, Gordon SM: Does the implementation of an Interferon-γ release assay in lieu of a tuberculin skin test increase acceptance of preventive therapy for latent tuberculosis among healthcare workers?. Infect Control Hosp Epidemiol. 2009, 30: 197-199. 10.1086/593965.CrossRefPubMed
30.
go back to reference Diel R, Wrighton-Smith P, Zellweger J-P: Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis. Eur Respir J. 2007, 30: 321-332. 10.1183/09031936.00145906.CrossRefPubMed Diel R, Wrighton-Smith P, Zellweger J-P: Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis. Eur Respir J. 2007, 30: 321-332. 10.1183/09031936.00145906.CrossRefPubMed
33.
go back to reference Bakir M, Millington KA, Soysal A, Deeks JJ, Efee S, Aslan Y, Dosanjh DPS, Lalvani A: Prognostic value of a T-cell based, interferon-gamma biomarker in children with tuberculosis contact. Ann Intern Med. 2008, 149: 777-786.CrossRefPubMedPubMedCentral Bakir M, Millington KA, Soysal A, Deeks JJ, Efee S, Aslan Y, Dosanjh DPS, Lalvani A: Prognostic value of a T-cell based, interferon-gamma biomarker in children with tuberculosis contact. Ann Intern Med. 2008, 149: 777-786.CrossRefPubMedPubMedCentral
34.
go back to reference van Zyl-Smit RN, Pai M, Peprah K, Meldau R, Kieck J, Juritz J, Badri M, Zumla A, Sechi LA, Bateman ED, Dheda K: Within-subject variability and boosting of T-cell Interferon- y responses after tuberculin skin testing. Am J Respir Crit Care Med. 2009, 180: 49-58. 10.1164/rccm.200811-1704OC.CrossRefPubMed van Zyl-Smit RN, Pai M, Peprah K, Meldau R, Kieck J, Juritz J, Badri M, Zumla A, Sechi LA, Bateman ED, Dheda K: Within-subject variability and boosting of T-cell Interferon- y responses after tuberculin skin testing. Am J Respir Crit Care Med. 2009, 180: 49-58. 10.1164/rccm.200811-1704OC.CrossRefPubMed
35.
go back to reference Menzies D, Pai M, Comstock G: Meta-analysis: New tests for the diagnosis of latent tuberculosis infection: Areas of uncertainty and recommendations for research. Ann Intern Med. 2007, 146: 340-354.CrossRefPubMed Menzies D, Pai M, Comstock G: Meta-analysis: New tests for the diagnosis of latent tuberculosis infection: Areas of uncertainty and recommendations for research. Ann Intern Med. 2007, 146: 340-354.CrossRefPubMed
Metadata
Title
Referrals for positive tuberculin tests in new health care workers and students: a retrospective cohort study
Authors
Yining Xu
Kevin Schwartzman
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2010
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-10-28

Other articles of this Issue 1/2010

BMC Public Health 1/2010 Go to the issue